Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gerry

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Behavior Genetics|October 13, 2009
Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samplesRiccardo E Marioni, Ian J Deary, Gordon D Murray, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2020
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID TrialMarat Fudim, Charles W Hopley, Zhen Huang, et al.
American Heart Journal|November 30, 2019
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trialRachael Ward, Zhen Huang, Frank W Rockhold, et al.
Circulation|November 15, 2016
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery DiseaseW Schuyler Jones, Iris Baumgartner, William R Hiatt, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID TrialJemi Galani, Hillary Mulder, Frank W Rockhold, et al.
Vascular Medicine (London, England)|July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trialJeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Journal of the American College of Cardiology|December 22, 2018
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID TrialCecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, et al.
Journal of Vascular Surgery|October 1, 2021
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trialNicholas Govsyeyev, Mark R Nehler, Cecilia C Low Wang, et al.
Journal of the American Heart Association|July 9, 2018
International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific CommitteeYejin Mok, Shoshana H Ballew, Lori D Bash, et al.
Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Behavior Genetics|October 13, 2009
Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samplesRiccardo E Marioni, Ian J Deary, Gordon D Murray, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2020
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID TrialMarat Fudim, Charles W Hopley, Zhen Huang, et al.
American Heart Journal|November 30, 2019
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trialRachael Ward, Zhen Huang, Frank W Rockhold, et al.
Circulation|November 15, 2016
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery DiseaseW Schuyler Jones, Iris Baumgartner, William R Hiatt, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID TrialJemi Galani, Hillary Mulder, Frank W Rockhold, et al.
Vascular Medicine (London, England)|July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trialJeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Journal of the American College of Cardiology|December 22, 2018
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID TrialCecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, et al.
Journal of Vascular Surgery|October 1, 2021
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trialNicholas Govsyeyev, Mark R Nehler, Cecilia C Low Wang, et al.
Journal of the American Heart Association|July 9, 2018
International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific CommitteeYejin Mok, Shoshana H Ballew, Lori D Bash, et al.
Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.
Pageof 7